A patient recently asked me a question I hear often in my lymphedema clinics in Leesburg and Ashburn: "Can I stop Complete Decongestive Therapy now that I have reached a plateau and can manage my symptoms on my own?"

I understand why she asked. She had worked hard through Phase 1. Her limb measurements had dropped significantly. She was feeling better, moving better, and wearing her compression garment daily. From the outside, it looked like the problem was solved.

But lymphedema and lipedema are chronic conditions. The underlying lymphatic impairment that caused the swelling in the first place does not resolve when the swelling goes down. It is controlled. And the moment you stop the behaviors that are controlling it, the swelling comes back, often faster and harder than before. The question is not whether lymphedema treatment is lifelong. It is. The question is what that lifelong commitment actually looks like in practice, and how to make it sustainable.

What Happens If You Stop Lymphedema Treatment After Improvement?

This is not a theoretical question. It has been studied in large, long-term cohorts, and the data are consistent.

The most important dataset comes from Vignes and colleagues at Hopital Cognacq-Jay in Paris, who followed 682 women with breast cancer-related lymphedema after completing intensive Phase 1 CDT. Treatment failure was defined as losing at least 50% of the volume reduction achieved during the intensive phase. The results followed a clear trajectory(1):

Patients who wore a daytime compression sleeve combined with overnight multilayer bandaging at least four nights per week cut their failure risk nearly in half (hazard ratio 0.53)(1). In an earlier Vignes cohort of 537 women, non-compliance with low-stretch bandaging raised the risk of volume regrowth by 55%, and non-compliance with the elastic sleeve raised it by 61%(2).

The Lasinski systematic review, published in PM&R and supported by the American Lymphedema Framework Project, synthesized the pattern across multiple studies: adherent patients preserved 90% of their initial volume reductions, while non-adherent patients lost 33% of their gains(3).

Why Is Lymphedema Maintenance Therapy Not Optional?

Phase 1 CDT is the intensive reduction stage: daily MLD sessions, short-stretch bandaging, decongestive exercises, and skin care protocols, typically running 3 to 5 sessions per week over 2 to 4 weeks. Cochrane-reviewed data show that compression bandaging alone produces 30 to 37% limb volume reduction in Phase 1, with MLD adding roughly another 7%(5). The results can be dramatic.

Phase 2 is where you protect those results for the rest of your life. It rests on four pillars(6):

The International Society of Lymphology's 2020 Consensus Document states this plainly: lymphedema "typically requires, as do other chronic disorders, lifelong care and attention"(4). A 2020 systematic review of all published lymphedema guidelines in the Journal of Vascular Surgery confirmed the consensus: every reviewed guideline recommends lifelong compression and ongoing CDT maintenance as the standard of care(7).

Plateau is not the finish line. Plateau is the success marker. Maintenance is the protection plan.

What Happens If You Stop Wearing Compression for Lymphedema?

This is the question patients ask most often, and the answer involves more than just fluid. When compression and drainage stop, the disease does not stay where you left it. It moves forward.

Chronic lymph stasis drives a well-characterized cycle of inflammation, fibrosis, and adipose deposition(8). Research in Lymphatic Research and Biology and the International Journal of Molecular Sciences shows that Th2 inflammation (driven by IL-4 and IL-13) promotes collagen deposition, which hardens tissue and converts pitting edema into non-pitting fibrotic swelling. Simultaneously, adipocytes (fat cells) proliferate in the subcutaneous compartment. Brorson's CT studies showed that long-standing lymphedema is dominated by fat, not fluid, and fat does not respond to compression or MLD the way fluid does(9).

This is why ISL Stage II is described as harder to reverse than Stage I, and Stage III (elephantiasis with hyperkeratosis) harder still. Every month of uncontrolled swelling narrows the window in which your limb can still be meaningfully reduced.

The infection data are particularly important. The LIMPRINT consortium's large international study found a 1-year cellulitis incidence of 11% and a lifetime prevalence of 22% in arm lymphedema(10). Risk scales with stage: odds of cellulitis are roughly 9 times higher in Stage III than in early disease. In a 2020 New England Journal of Medicine randomized trial, compression reduced cellulitis recurrence from 40% to 15% (hazard ratio 0.23; number needed to treat = 4)(11). Each cellulitis episode causes further scarring of lymphatic vessels, accelerating the very disease you are trying to control.

Can Lipedema Be Cured Permanently?

I hear this question from lipedema patients as well, and the honest answer is no. Every major international guideline, including the 2021 U.S. Standard of Care (Herbst et al.), the 2024 German S2k guidelines, and a 2025 systematic review in Obesity Reviews, describes lipedema as chronic and progressive(12)(13). It meets all four WHO chronic disease criteria.

Progression tracks hormonal transitions (puberty, pregnancy, menopause), weight changes, trauma, and surgery. Over time, many patients develop secondary lymphatic involvement, a condition called lipo-lymphedema, which is why compression, MLD, and exercise remain lifelong mainstays even for patients who have had liposuction(13). Liposuction can remove diseased adipose tissue and provide meaningful relief, but it does not cure the underlying condition. Long-term results depend on continued conservative care.

The maintenance commitment for lipedema patients follows the same logic as lymphedema: the disease does not stop when treatment stops. The goal is to slow progression, manage symptoms, and preserve function for as long as possible.

How Do You Make Lymphedema Maintenance Therapy Sustainable for Life?

I want to be honest about something: Phase 2 is real work. Systematic reviews of qualitative studies describe lymphedema self-management as "a lifetime commitment and a challenge"(14). Patients in focus groups report spending 150 minutes or more per week on self-care, plus 12 or more hours of daily compression. The psychosocial burden is documented: emotional distress, body image disruption, financial strain, and social isolation(15).

Treatment fatigue is real, and pretending otherwise would be a disservice to my patients. But the evidence also identifies what helps:

Education and self-efficacy building. Patients who understand their condition and feel competent managing it sustain adherence longer. A 2020 randomized controlled trial found that structured group education outperformed routine care on quality of life and fear of recurrence(16). This is why I invest significant time in teaching every patient the "why" behind each component of their home program, not just the "how."

Simplified, individualized regimens. Custom-fitted garments, donning aids, velcro wraps, and pneumatic compression devices all reduce the burden of daily management and improve compliance. Not every patient needs the same protocol. The goal is to find the minimum effective maintenance plan that your life can actually sustain.

Ongoing therapist partnership. Best practice guidelines published in peer-reviewed journals recommend ongoing specialist follow-up every 6 to 12 months indefinitely(17). Adjustments to garments, re-measurement, and brief return-to-Phase-1 intensives during flares are normal. Phase 2 is dynamic, not static.

Lauren's words capture exactly what I aim for. My job is not to keep you in my clinic forever. My job is to give you the knowledge, skills, and confidence to manage your condition independently, with periodic check-ins to catch early warning signs (ring tightness, morning heaviness, a changing Stemmer's sign, or the feeling that compression is "not working as well") before they become setbacks.

What Does Long-Term Care Actually Look Like for Real Patients?

The maintenance mindset is something I see reflected in patients across my practice, not just lymphedema patients. The ones who do best are the ones who view their clinician as a long-term partner, not a short-term fix.

What Craig, Constance, and Remie share is a relationship with their care that extends beyond the acute problem. Craig has been coming for two years. Constance calls her therapist "a permanent part of my wellness plan." Remie found relief from inflammation and swelling that changed her daily life. For lymphedema and lipedema patients, this long-term partnership is not a luxury. It is the clinical standard of care(4)(7).

Does Insurance Cover Compression Garments for Lymphedema?

Cost is one of the most common barriers to long-term adherence, and I want patients to know about a significant recent change. The Lymphedema Treatment Act, which went into effect on January 1, 2024, now requires Medicare (and most Medicare-aligned plans) to cover three daytime and two nighttime compression garments per affected body part every six months(18). Many patients are unaware that coverage has expanded.

For patients in my private-pay practice, I always provide detailed receipts with the necessary codes for insurance reimbursement. Cost should never be the reason someone stops a treatment that the evidence says they need for life.

The Plateau Is Proof That the Work Is Working

If you have reached a plateau in your CDT, that is a genuine accomplishment. It means your lymphatic system, with the help of intensive therapy, has found a new equilibrium. But the evidence from systematic reviews, large prospective cohorts, international consensus documents, and randomized trials converges on a single message: that equilibrium is actively maintained, not permanent(3)(4).

Stopping Phase 2 produces measurable volume regression in most patients within months. It accelerates fibrotic and adipose tissue changes that are difficult to reverse. It multiplies cellulitis risk. And it shortens the window in which treatment remains maximally effective. Lymphedema and lipedema are, by every authoritative definition, lifelong. The good news is that with sustained Phase 2 care, the great majority of patients maintain their gains and avoid the cascade of complications that defines untreated disease.

As Pat Nolan, one of my long-term patients, puts it: Dr. Grace "continually helps motivate me to stay on track... I feel supported, listened to, and confident in her care." That is what Phase 2 should feel like. Not a burden, but a partnership.

If you are navigating a plateau, experiencing early signs of rebound, or need to recalibrate your maintenance plan, visit my Certified Lymphedema Therapist page to schedule a maintenance visit, or call (703) 637-8252. The research is clear that ongoing specialist partnership is one of the strongest predictors of long-term success.

In health,
Dr. Grace Villaver, DPT, CLT
Level Up Rehabilitation Services, LLC
42910 Winkel Dr, Unit #105, Ashburn, VA 20147
(703) 637-8252  |  Mon-Fri, 7 AM - 5 PM